Literature DB >> 1620965

Bovine spongiform encephalopathy: case-control studies of calf feeding practices and meat and bonemeal inclusion in proprietary concentrates.

J W Wilesmith1, J B Ryan, W D Hueston.   

Abstract

Following the identification of meat and bonemeal as the most likely source of exposure for the occurrence of bovine spongiform encephalopathy (BSE) in Great Britain case-control studies were initiated to investigate this hypothesis. These involved a comparison of the consumption of specific proprietary calf feedstuffs, and whether or not meat and bonemeal had been included, between animals born in 1983-84 in BSE-unaffected herds and confirmed cases of BSE also born in 1983-84. The feeding of proprietary concentrates containing meat and bonemeal was found to be a statistically significant risk factor for the occurrence of BSE. These studies therefore support the initial hypothesis that BSE occurred as a result of exposure to a scrapie-like agent via meat and bonemeal.

Entities:  

Mesh:

Year:  1992        PMID: 1620965     DOI: 10.1016/0034-5288(92)90032-w

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  16 in total

1.  The epidemiology of BSE in cattle herds in Great Britain. I. Epidemiological processes, demography of cattle and approaches to control by culling.

Authors:  C A Donnelly; N M Ferguson; A C Ghani; M E Woolhouse; C J Watt; R M Anderson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-07-29       Impact factor: 6.237

2.  The epidemiology of BSE in cattle herds in Great Britain. II. Model construction and analysis of transmission dynamics.

Authors:  N M Ferguson; C A Donnelly; M E Woolhouse; R M Anderson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-07-29       Impact factor: 6.237

3.  Modelling BSE trend over time in Europe, a risk assessment perspective.

Authors:  Christian Ducrot; Carole Sala; Giuseppe Ru; Aline de Koeijer; Hazel Sheridan; Claude Saegerman; Thomas Selhorst; Mark Arnold; Miroslaw P Polak; Didier Calavas
Journal:  Eur J Epidemiol       Date:  2010-04-13       Impact factor: 8.082

4.  PRNP and SPRN genes polymorphism in atypical bovine spongiform encephalopathy cases diagnosed in Polish cattle.

Authors:  Artur Gurgul; Mirosław Paweł Polak; Magdalena Larska; Ewa Słota
Journal:  J Appl Genet       Date:  2012-06-22       Impact factor: 3.240

Review 5.  Variant Creutzfeldt-Jakob disease: a summary of current scientific knowledge in relation to public health.

Authors:  M B Coulthart; N R Cashman
Journal:  CMAJ       Date:  2001-07-10       Impact factor: 8.262

6.  Hydrated autoclave pretreatment enhancement of prion protein immunoreactivity in formalin-fixed bovine spongiform encephalopathy-affected brain.

Authors:  M Haritani; Y I Spencer; G A Wells
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

7.  A temporal-spatial analysis of bovine spongiform encephalopathy in Irish cattle herds, from 1996 to 2000.

Authors:  Hazel A Sheridan; Guy McGrath; Paul White; Richard Fallon; Mohamed M Shoukri; S Wayne Martin
Journal:  Can J Vet Res       Date:  2005-01       Impact factor: 1.310

8.  Comparative molecular analysis of the abnormal prion protein in field scrapie cases and experimental bovine spongiform encephalopathy in sheep by use of Western blotting and immunohistochemical methods.

Authors:  Stéphane Lezmi; Stuart Martin; Stéphanie Simon; Emmanuel Comoy; Anna Bencsik; Jean-Philippe Deslys; Jacques Grassi; Martin Jeffrey; Thierry Baron
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

9.  Decision support tools for clinical diagnosis of disease in cows with suspected bovine spongiform encephalopathy.

Authors:  C Saegerman; N Speybroeck; S Roels; E Vanopdenbosch; E Thiry; D Berkvens
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

10.  Time trends in exposure of cattle to bovine spongiform encephalopathy and cohort effect in France and Italy: value of the classical Age-Period-Cohort approach.

Authors:  Carole Sala; Giuseppe Ru
Journal:  BMC Vet Res       Date:  2009-09-18       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.